1642223

Sumatriptan succinate Related Compound C

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): {3-[2-(Dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl}-N-methylmethanesulfonamide hemisuccinate salt
• Empirical Formula (Hill Notation): C₁₅H₂₃N₃O₃S · 0.5C₄H₆O₄
• Molecular Weight: 384.47
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• grade: pharmaceutical primary standard
• API family: sumatriptan
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• storage temp.: 2-8°C

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Sumatriptan succinate Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Sumatriptan Succinate
• Sumatriptan
• Sumatriptan Nasal Spray
• Sumatriptan Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS08
• Signal Word: Warning
• Hazard Statements: H361d,H412
• Precautionary Statements: P202 - P273 - P280 - P308 + P313 - P405 - P501
• Hazard Classifications: Aquatic Chronic 3 - Repr. 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 2
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable